Skip to Main Content

Author Details

Seong Beom Ahn
Macquarie Medical School, Macquarie University
2011
25
12
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36769148Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice.Int J Mol Sci2023
36769148Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice.Int J Mol Sci2023
37041200Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.Br J Cancer2023
37041200Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.Br J Cancer2023
34981682SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.J Korean Med Sci2022
35813465The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.Int J Biol Sci2022
34981682SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.J Korean Med Sci2022
35813465The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.Int J Biol Sci2022
32047889Mass spectrometry-based protein identification in proteomics-a review.Brief Bioinform2021
32047889Mass spectrometry-based protein identification in proteomics-a review.Brief Bioinform2021
33752330Use of a Recombinant Biomarker Protein DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins.J Proteome Res2021
34680327Involvement of Kynurenine Pathway in Hepatocellular Carcinoma.Cancers (Basel)2021
33752330Use of a Recombinant Biomarker Protein DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins.J Proteome Res2021
34680327Involvement of Kynurenine Pathway in Hepatocellular Carcinoma.Cancers (Basel)2021
33067450A high-stringency blueprint of the human proteome.Nat Commun2020
31914823Proteomic investigations into resistance in colorectal cancer.Expert Rev Proteomics2020
32030527Improved sensitivity in cell surface protein detection by combining chemical labeling with mechanical lysis in a colorectal cancer cell model.Biotechnol Lett2020
33067450A high-stringency blueprint of the human proteome.Nat Commun2020
32030527Improved sensitivity in cell surface protein detection by combining chemical labeling with mechanical lysis in a colorectal cancer cell model.Biotechnol Lett2020
31914823Proteomic investigations into resistance in colorectal cancer.Expert Rev Proteomics2020
31046287In Silico Peptide Repertoire of Human Olfactory Receptor Proteomes on High-Stringency Mass Spectrometry.J Proteome Res2019
31467500Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel.Clin Proteomics2019
31402590Proteomics Reveals Cell-Surface Urokinase Plasminogen Activator Receptor Expression Impacts Most Hallmarks of Cancer.Proteomics2019
31046287In Silico Peptide Repertoire of Human Olfactory Receptor Proteomes on High-Stringency Mass Spectrometry.J Proteome Res2019
31467500Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel.Clin Proteomics2019
31402590Proteomics Reveals Cell-Surface Urokinase Plasminogen Activator Receptor Expression Impacts Most Hallmarks of Cancer.Proteomics2019
27975291A Systematic Bioinformatics Approach to Identify High Quality Mass Spectrometry Data and Functionally Annotate Proteins and Proteomes.Methods Mol Biol2017
28895742Human Prestin: A Candidate PE1 Protein Lacking Stringent Mass Spectrometric Evidence?J Proteome Res2017
29152306Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients.Biomark Res2017
27975291A Systematic Bioinformatics Approach to Identify High Quality Mass Spectrometry Data and Functionally Annotate Proteins and Proteomes.Methods Mol Biol2017
28117396Accelerating the search for the missing proteins in the human proteome.Nat Commun2017
28117396Accelerating the search for the missing proteins in the human proteome.Nat Commun2017
29152306Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients.Biomark Res2017
28895742Human Prestin: A Candidate PE1 Protein Lacking Stringent Mass Spectrometric Evidence?J Proteome Res2017
27465915Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.Blood2016
27465915Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.Blood2016
25692297Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.PLoS One2015
25692297Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.PLoS One2015
25987887A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.Clin Proteomics2015
25979773Is isolation of comprehensive human plasma peptidomes an achievable quest?J Proteomics2015
25987887A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.Clin Proteomics2015
25979773Is isolation of comprehensive human plasma peptidomes an achievable quest?J Proteomics2015
24423664A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking.J Struct Biol2014
25318615Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.J Proteome Res2014
24423664A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking.J Struct Biol2014
24821188Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.PLoS One2014
25318615Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.J Proteome Res2014
24821188Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.PLoS One2014
21168580Discovery of a novel biomarker in the urine in women with endometriosis.Fertil Steril2011
21168580Discovery of a novel biomarker in the urine in women with endometriosis.Fertil Steril2011
  • 1 - 50 of 50

Recommended Authors

Andrew Macklin
Margaret Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Ankit Sinha
Max Planck Institute of Biochemistry
Career Start Year 2011
Number of shared co-authors 0
Fabian Coscia
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 2011
Number of shared co-authors 1
Meike de Wit
The Netherlands Cancer Institute
Career Start Year 2010
Number of shared co-authors 2
Mar??a Gonz??lez-Gonz??lez
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Career Start Year 2010
Number of shared co-authors 15
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Yansheng Liu
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 5
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
Elisa Pin
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 4
Ioannis Prassas
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 0
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 3
Alex Ignatchenko
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2005
Number of shared co-authors 0
Henrik J Johansson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 3
Bing Zhang
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 11
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 1
Sharon J Pitteri
Stanford University
Career Start Year 2003
Number of shared co-authors 9
Kai St??hler
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 1
Kieran Wynne
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 14
Tamar Geiger
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 5
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 15
Parag Mallick
Stanford University
Career Start Year 2000
Number of shared co-authors 12
Tao Liu
Pacific Northwest National Laboratory
Career Start Year 1998
Number of shared co-authors 10
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 4
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 6
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 5
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 9
Samir M Hanash
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 19

Collaborators

Mark S Baker
Macquarie University
Co-authored papers 15
Edouard C Nice
Monash University
Co-authored papers 10
Shoba Ranganathan
Macquarie University
Co-authored papers 7
Subash Adhikari
Institute of Tibetan Plateau Research, Chinese Academy of Sciences
Co-authored papers 5
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 1
Ileana M Cristea
Princeton University
Co-authored papers 1
Sudhir Srivastava
National Cancer Institute
Co-authored papers 1
Ruedi Aebersold
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 1
Richard A Scolyer
Co-authored papers 1
Fernando J Corrales
National Center for Biotechnology
Co-authored papers 1
Rebekah L Gundry
Medical College of Wisconsin
Co-authored papers 1
Gilberto B Domont
Institute of Chemistry, Federal University of Rio de Janeiro
Co-authored papers 1
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 1
Juan Antonio Vizca??no
EMBL-European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 1
Ulrike Kusebauch
Institute for Systems Biology
Co-authored papers 1
Gaetan Burgio
College of Health and Medicine, The Australian National University
Co-authored papers 1
Yves Vandenbrouck
University Grenoble Alpes, INSERM, CNRS
Co-authored papers 1
Robert L Moritz
Institute for Systems Biology
Co-authored papers 1
Sanjeeva Srivastava
Indian Institute of Technology Bombay
Co-authored papers 1
Stephen R Pennington
UCD Conway Institute, University College Dublin
Co-authored papers 1
Sung Eun Kim
Haeundae Paik Hospital, Inje University College of Medicine
Co-authored papers 1
Christopher M Overall
University of British Columbia
Co-authored papers 1
Joshua L Justice
Princeton University
Co-authored papers 1
Sara A Wennersten
University of Colorado
Co-authored papers 1
Jochen M Schwenk
KTH Royal Institute of Technology
Co-authored papers 1
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Co-authored papers 1
Amos Bairoch
University of Geneva
Co-authored papers 1
Nuno Bandeira
University of California
Co-authored papers 1
Fei Liu
Macquarie University
Co-authored papers 1
Joshua LaBaer
Biodesign Institute, Arizona State University
Co-authored papers 1
Release 1.2